ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $184,000 | -79.0% | 115,100 | -76.9% | 0.12% | -84.0% |
| Q1 2021 | $876,000 | -49.1% | 497,842 | -43.6% | 0.72% | -9.9% |
| Q4 2020 | $1,722,000 | +34.5% | 883,214 | +65.0% | 0.80% | +30.7% |
| Q3 2020 | $1,280,000 | -66.4% | 535,324 | -58.8% | 0.61% | -62.7% |
| Q2 2020 | $3,807,000 | +6.4% | 1,299,300 | +4.6% | 1.63% | -2.3% |
| Q1 2020 | $3,579,000 | +46.7% | 1,242,700 | +126.6% | 1.67% | +23.7% |
| Q3 2019 | $2,440,000 | +239.4% | 548,409 | +195.3% | 1.35% | +272.7% |
| Q2 2019 | $719,000 | – | 185,721 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |